Search results for “Hemoglobin urine” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 258 patents, we discovered top 24 key players by total patent application. Alexion Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc., Omeros Corp. are dominant in this area. They take 56.98% of the total patent filing.
Alexion Pharmaceuticals, Inc.
Connecticut, United States
Patent: 74
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 44
Omeros Corp.
Washington, United States
Patent: 29
BioCryst Pharmaceuticals, Inc.
Alabama, United States
Patent: 19
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 18
Silence Therapeutics GmbH
Berlin, Germany
Patent: 17
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 9
Apellis Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 6
Homology Medicines, Inc.
Massachusetts, United States
Patent: 5
Ra Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 5
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 204 patents applied in the last 5 years. We discover 23 most active companies in this area. The fast-growing Alexion Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc., BioCryst Pharmaceuticals, Inc. take 51.47% of patent filing during this period.
Alexion Pharmaceuticals, Inc.
Connecticut, United States
Patent: 59
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 27
BioCryst Pharmaceuticals, Inc.
Alabama, United States
Patent: 19
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 18
Silence Therapeutics GmbH
Berlin, Germany
Patent: 17
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 9
University of Leicester
LEICESTER, United Kingdom
Patent: 8
Omeros Corp.
Washington, United States
Patent: 8
Apellis Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 6
Ra Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 5
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 204 patents in last 5 years, we discover 19 new entrants. BioCryst Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd., Silence Therapeutics GmbH are the most active new entrants in this area.
BioCryst Pharmaceuticals, Inc.
Alabama, United States
Patent: 19
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 18
Silence Therapeutics GmbH
Berlin, Germany
Patent: 17
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 9
Apellis Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 6
Ra Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 5
Homology Medicines, Inc.
Massachusetts, United States
Patent: 5
Novartis AG
Basel-Stadt, Switzerland
Patent: 3
Annexon, Inc.
California, United States
Patent: 3
Shanghai Meiyue Biotechnology Dev Co Ltd
Shanghai Shi, China
Patent: 2
Research Institutions
Order by:
Innovation Intensity
With the analysis among 26 patents, we discovered top 1 universities and scientific research institutions by total patent application.
University of Leicester
LEICESTER, United Kingdom
Patent: 25
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: